Data / Form D filings / Melt Pharmaceuticals, Inc.
Melt Pharmaceuticals, Inc.: Form D filings
Melt Pharmaceuticals, Inc., a pharmaceuticals company in Brentwood, TN, filed 11 Form D notices with the SEC between 2019 and 2024. The latest, on April 8, 2024, reports $42.3 million sold of a $47.8 million offering to 309 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5511 VIRGINIA WAY, SUITE 300, Brentwood, TN, 37027
- Phone
- (858) 704-4042
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1767398
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | Amendment | $47,763,600 | $42,292,450 | $5,471,150 | 309 | Jul 28, 2023 | sec.gov |
| Mar 11, 2024 | Amendment | $47,763,600 | $41,552,780 | $6,210,820 | 300 | Jul 28, 2023 | sec.gov |
| Feb 12, 2024 | Amendment | $47,763,600 | $39,485,520 | $8,278,080 | 287 | Jul 28, 2023 | sec.gov |
| Jan 9, 2024 | Amendment | $47,763,600 | $38,980,960 | $8,782,640 | 276 | Jul 28, 2023 | sec.gov |
| Dec 11, 2023 | Amendment | $30,000,000 | $20,181,312 | $9,818,688 | 272 | Jul 28, 2023 | sec.gov |
| Nov 13, 2023 | Amendment | $30,000,000 | $19,551,717 | $10,448,283 | 264 | Jul 28, 2023 | sec.gov |
| Oct 13, 2023 | Amendment | $30,000,000 | $17,145,928 | $12,854,072 | 215 | Jul 28, 2023 | sec.gov |
| Sep 12, 2023 | Amendment | $30,000,000 | $10,594,468 | $19,405,532 | 116 | Jul 28, 2023 | sec.gov |
| Aug 11, 2023 | New notice | $30,000,000 | $1,808,970 | $28,191,030 | 37 | Jul 28, 2023 | sec.gov |
| Apr 5, 2019 | Amendment | $25,750,000 | $11,435,000 | $14,315,000 | 165 | Jan 30, 2019 | sec.gov |
| Feb 13, 2019 | New notice | $25,750,000 | $10,790,000 | $14,960,000 | 152 | Jan 30, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Larry Dillaha | Executive Officer, Director | |
| Brad Osborne | Executive Officer |
Every Form D from the week of Apr 8, 2024 · All recent filings in Tennessee · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Melt Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.